Bharavi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.43 M
- Company Age 47 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.53%
- Profit Growth 33.11%
- Ebitda 4.71%
- Net Worth 0.27%
- Total Assets 1.92%
About Bharavi Pharmaceuticals
Bharavi Pharmaceuticals Limited (BPL) is a Public Limited Indian Non-Government Company incorporated in India on 28 April 1977 and has a history of 47 years and nine months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Bharavi Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.43 M, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Shah, Bhavna Shah, and Tirth Shah serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24249GJ1977PLC003006
-
Company No.
003006
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
28 Apr 1977
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Bharavi Pharmaceuticals Limited offer?
Bharavi Pharmaceuticals Limited offers a wide range of products and services, including Ayurvedic & Herbal Health Supplement, Herbal Sexual Health Supplement, Common Disease Medicines, Hair Growth Medicine, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Digestive Drugs, Herbal Piles Medicine, Herbal Piles Capsules and Tablets, Third Party Manufacturing Consultancy.
Who are the key members and board of directors at Bharavi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Shah
|
Managing Director | 21-Mar-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Bhavna Shah
|
Whole-Time Director | 18-Nov-2010 | Current |
|
Tirth Shah
|
Whole-Time Director | 05-Jul-2018 | Current |
Financial Performance of Bharavi Pharmaceuticals.
Bharavi Pharmaceuticals Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 0.53% decrease. The company also saw a substantial improvement in profitability, with a 33.11% increase in profit. The company's net worth moved up by a moderate rise of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bharavi Pharmaceuticals?
In 2019, Bharavi Pharmaceuticals had a promoter holding of 96.75% and a public holding of 3.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bharavi Pharmaceuticals?
Bharavi Pharmaceuticals has a workforce of 3 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bharavi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharavi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
